Prevalence and prognosis of increased pancreatic enzymes in patients with COVID-19: A systematic review and meta-analysis.
Windsor, John A
MetadataShow full item record
AbstractIntroduction: The prevalence of increased pancreatic enzymes (elevated serum amylase and/or lipase) and its relationship to clinical outcomes in patients with coronavirus disease 2019 (COVID-19) infection is not known. Methods: A systematic review and meta-analysis of relevant studies reporting prevalence and impact of increased pancreatic enzymes (defined as an elevation in amylase and/or lipase levels above the upper limit of normal [ULN] value) in COVID-19 was undertaken. Results: A total of 36,496 patients from 21 studies were included for this meta-analysis. The overall prevalence and mortality for increased pancreatic enzymes (>ULN) in COVID-19 were 25.4% (95% CI, 15.8%-36.2%) and 34.6% (95% CI, 25.5%-44.4%), respectively. The overall prevalence and mortality for increased pancreatic enzymes (>3 × ULN) were 6.1% (95% CI, 3.6%-9.2%) and 39.2% (95% CI, 18.7%-61.6%), respectively. Patients with increased pancreatic enzymes, including elevated serum lipase or amylase of either type, had worse clinical outcomes, including need for ICU admission, mechanical ventilation and mortality. Discussion: Increased pancreatic enzymes is frequent and may exacerbate the consequences of COVID-19 infection.
Rights/TermsCopyright © 2022 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18445
- Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review.
- Authors: Zhou Y, Ge YT, Yang XX, Cai Q, Ding YB, Hu LH, Lu GT
- Issue date: 2022
- [Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
- Authors: National Research Coordination Group of the Critically Ill Children Secondary Pancreatic Injury
- Issue date: 2016 Sep
- Analysis of Outcomes in COVID-19 Patients With Varying Degrees of Hyperlipasemia.
- Authors: Benias PC, Inamdar S, Wee D, Liu Y, Buscaglia JM, Satapathy SK, Trindade AJ, Northwell COVID-19 Research Consortium
- Issue date: 2021 Oct 1
- Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study.
- Authors: Barlass U, Wiliams B, Dhana K, Adnan D, Khan SR, Mahdavinia M, Bishehsari F
- Issue date: 2020 Jul
- Elevated amylase and lipase levels in the neurosurgery intensive care unit.
- Authors: Lee CC, Chung WY, Shih YH
- Issue date: 2010 Jan